Peptide Synthesis Market Poised to Witness High
Growth owing to Advancements in Custom Peptide Synthesis

The global peptide synthesis market
is a vital segment of the healthcare industry. Peptides are short chains of
amino acids that can be used in drug development and other medical
applications. Custom peptide synthesis allows researchers to procure short run
peptides for clinical trials and research projects in a cost-effective manner.
Peptide synthesis is carried out through either solid-phase or liquid-phase
methods and has applications across various domains including pharmaceutical,
biotechnology, diagnostic and chemical industries. The availability of custom
peptide synthesis services has accelerated research activities in drug
discovery, immunology and protein-protein interaction studies.



The Global peptide synthesis market is
estimated to be valued at US$ 490.58 Mn in 2024 and is expected to exhibit a
CAGR of 7.4% over the forecast period 2024 To 2031.



Key Takeaways



Key players operating in the peptide synthesis market include GenScript Biotech
Corporation, Merck KGaA, ThermoFisher Scientific Inc., Syngene, Lonza, Novo
Nordisk A/S, Bachem Holding AG, Gyros Protein Technologies, Creative
Diagnostics, CEM Corporation, PuroSynth.



The Peptide
Synthesis Market Trends  for
customized peptides from biotech and pharma companies for pre-clinical and
clinical research. Furthermore, the development of novel solid phase peptide
synthesis techniques such as SPOT synthesis will further augment the
capabilities of peptide synthesis platforms.



Technological advancements in the field of automated peptide synthesis such as
microwave assisted peptide synthesis is also expected to support market growth
over the forecast period. These technological upgrades help minimize reaction
times and improve reproducibility of results.

Get
More Insights On, Peptide
Synthesis Market